approval · primary record
DUPILUMAB
FDA · BLA · 2026-07-15
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-07-15 |
| Brand | DUPIXENT |
| Sponsor | REGENERON PHARMACEUTICALS |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:40.073Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DUPILUMAB:2026-07-15
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.